Wide Media Coverage May Signal Your Stock Has Peaked
Posted in General Email This Post No comments yet
Usually, when a stock you own gets good press, it often translates into profits. Nobody wants to miss “the next big thing,” and that can fuel buying interest in an issue. Interestingly, Investor Business Daily’s Scott Stoddard suggests in his piece “Wide Media Coverage May Signal Your Stock Has Peaked,” that too much media coverage [...]
One of the most common ways investors evaluate a company is to compare its stock performance and valuation to other companies in the same sector. A look at relative sales, earnings and growth rates often can lead to the identification of an issue that has the potential to trade higher, or conversely, might make a [...]
When you have an important decision to make in your life, do you ask just one person for advice? If you’re like most folks, the answer is no. You probably ask three people… four… even ten. So why should your portfolio be any different? The short answer is it shouldn’t. I fully believe that, and [...]
Upcoming Catalysts Could Push ChemoCentryx to Double In 2013
Posted in Stock Picks Email This Post No comments yet
Traders are always on the lookout for stocks that have strong growth potential, dubbing the “potential 10-baggers,” or “potential doublers.” After all, who wouldn’t want to double their investment money, or better still, get back 1,000% returns? In a lengthy and detailed piece for SeekingAlpha titled, “Upcoming Catalysts Could Push ChemoCentryx to Double in 2013,” [...]
5 Dividend Stocks Ready to Give You a Raise
Posted in Stock Picks Email This Post No comments yet
Although dividend-paying stocks aren’t in vogue with the fast-money crowd, they’ve always had a strong following among institutional investors and funds looking to lock in gains on less risky, dividend-generating issues In his Stockpikr.com piece “5 Dividend Stocks Ready to Give You a Raise,” Jonas Elmerraji talks about the current value of owning dividend-paying stocks, [...]
In today’s Trading Tip, author Jason Napodano takes a close look at the potential of an interesting up-and-coming pharmaceutical concern Zalicus (ZLCS), in his piece for SeekingAlpha, “Watching Zalicus Like a Hawk.” The company is currently in advanced Phase II trials for its anti-cancer compound called Z160. “Zalicus is starting to look very interesting at [...]
Sell Sign Can Be Urgent Or Not: How Do You Tell?
Posted in General Email This Post No comments yet
A specialty of Investors Business Daily (IBD) is alerting readers how to read the tea leaves when trading stocks. Not only do they highlight plays that appear to be technically primed to move higher; they also provide insight about when and why it might be a good time to sell a stock. That’s precisely what [...]
In the stock market, especially for small caps, momentum can carry issue prices higher with great speed. In his regular column for Stockpikr.com, Robert Pedone brings readers attention to “3 Under-$10 Stocks Making Big Moves.” “Stocks that are making large moves like these are favorites among short-term traders,” Pedone writes, “because they can jump into [...]
Investing In Disruptive Business Models: SolarCity And Better Energy
Posted in General Email This Post No comments yet
When you hear the expression “disruptive business model” in the context of a publically-traded company, it always gets your attention. If a company truly has a paradigm-shifting gameplan that’s working, it can lead to healthy and relatively quick returns for shareholders. In his lengthy SeekingAlpha piece, “Investing in Disruptive Business Models: SolarCity and Better Energ,” [...]
3 Companies Aiming For The $1.2B Opioid Addiction Market
Posted in Stock Picks Email This Post No comments yet
Addiction touches the lives of most of us in one way or another, whether through personal experience or having friends or family members who have struggled with the disease. The market for helping people beat their addictions is huge and growing, and that’s one of the reasons SeekingAlpha author “Healthcare Specialist” highlights three promising addiction-treatment [...]



